Komori
M&A and Subsidiary Changes6171C.E.Management Integrated Laboratory Co.LtdInformation and Communications, Services and Others

Notice concerning a share accumulation prescribed by Cabinet Order as an act equivalent to a tender offer for C.E.Management Integrated Laboratory Co.Ltd (Securities Code 6171)

It has been decided that 株式会社Feel will acquire 728,800 shares of C.E.Management Integrated Laboratory Co.Ltd from Shimodaira Minako (下平美奈子) and Shimodaira Marina (下平真里奈), giving it a 5.13% ownership stake on a voting rights basis. 株式会社Feel intends to hold the acquired shares over the long term as a stable shareholder.

Worth reading
22Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
5.13
%
Wording
Definitive
How definitive the wording is.

This transaction

This share acquisition
CounterpartyShimodaira Minako (下平美奈子), Shimodaira Marina (下平真里奈)
Disclosing companyC.E.Management Integrated Laboratory Co.Ltd
C.E.Management Integrated Laboratory Co.LtdVoting rights ownership percentageNumber of shares acquired 728,800 shares; number of voting rights: Not disclosed

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.

Execution Date / Effective Date18 August 2026
This transaction
ItemDetails
Transaction nameThis share acquisition
Counterparty nameShimodaira Minako (下平美奈子), Shimodaira Marina (下平真里奈)
Name of the Subject CompanyC.E.Management Integrated Laboratory Co.Ltd
Number of shares acquired728,800 shares; number of voting rights: Not disclosed
Voting rights ownership percentageAfter 5.13% (before not disclosed)
Execution Date / Effective Date18 August 2026
Items this document does not state (26)
Business Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceDate of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The purpose is to hold the shares long term as a stable shareholder.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice concerning a share accumulation prescribed by Cabinet Order as an act equivalent to a tender offer for C.E.Management Integrated Laboratory Co.Ltd (Securities Code 6171) | C.E.Management Integrated Laboratory Co.Ltd (6171) timely disclosure | Komori